Peregrine Pharmaceuticals Inc., of Tustin, Calif., said a previously approved 1-for-7 reverse split of its outstanding shares of common stock took effect Friday, July 7, and will begin trading on Nasdaq Monday, July 10, on a split-adjusted basis under the existing trading symbol PPHM.